Numeta G 16% E® (nutrient solution for term infants and children up to 2 years of age): Possible risk of hypermagnesemia
2013.10.09
Active substance: nutrient solution for term infants and children up to 2 years of age
The company Baxter Deutschland GmbH is sending out information that administration of the medicinal product Numeta G 16% E® to term infants and children up to 2 years of age can possibly lead to the risk of hypermagnesemia.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN